Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells.
Int J Mol Sci. 2021 Aug 27;22(17):9283. doi: 10.3390/ijms22179283.
Int J Mol Sci. 2021.
PMID: 34502189
Free PMC article.
Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer.
Ahmadpour ST, Mahéo K, Servais S, Brisson L, Dumas JF.
Ahmadpour ST, et al.
Int J Mol Sci. 2020 Oct 28;21(21):8031. doi: 10.3390/ijms21218031.
Int J Mol Sci. 2020.
PMID: 33126604
Free PMC article.
Review.
Item in Clipboard
The Long Non-Coding RNA SAMMSON Is a Regulator of Chemosensitivity and Metabolic Orientation in MCF-7 Doxorubicin-Resistant Breast Cancer Cells.
Orre C, Dieu X, Guillon J, Gueguen N, Ahmadpour ST, Dumas JF, Khiati S, Reynier P, Lenaers G, Coqueret O, Chevrollier A, Mirebeau-Prunier D, Desquiret-Dumas V.
Orre C, et al. Among authors: ahmadpour st.
Biology (Basel). 2021 Nov 9;10(11):1156. doi: 10.3390/biology10111156.
Biology (Basel). 2021.
PMID: 34827149
Free PMC article.
Item in Clipboard
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.
Ahmadpour ST, Orre C, Bertevello PS, Mirebeau-Prunier D, Dumas JF, Desquiret-Dumas V.
Ahmadpour ST, et al.
Int J Mol Sci. 2023 Nov 2;24(21):15897. doi: 10.3390/ijms242115897.
Int J Mol Sci. 2023.
PMID: 37958880
Free PMC article.
Review.
Item in Clipboard
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.
Roth GS, Macek Jilkova Z, Zeybek Kuyucu A, Kurma K, Ahmad Pour ST, Abbadessa G, Yu Y, Busser B, Marche PN, Leroy V, Decaens T.
Roth GS, et al.
Mol Cancer Ther. 2017 Oct;16(10):2157-2165. doi: 10.1158/1535-7163.MCT-16-0602-T. Epub 2017 May 31.
Mol Cancer Ther. 2017.
PMID: 28566435
Item in Clipboard
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
Jilkova ZM, Kuyucu AZ, Kurma K, Ahmad Pour ST, Roth GS, Abbadessa G, Yu Y, Schwartz B, Sturm N, Marche PN, Hainaut P, Decaens T.
Jilkova ZM, et al.
Oncotarget. 2018 Jan 23;9(13):11145-11158. doi: 10.18632/oncotarget.24298. eCollection 2018 Feb 16.
Oncotarget. 2018.
PMID: 29541403
Free PMC article.
Item in Clipboard
Cite
Cite